Processa Pharmaceuticals, Inc. (PCSA) › Capital ExpendituresProcessa Pharmaceuticals, Inc. (PCSA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2012: $334.3K2013: $27.7K2014: $11.0K2015: $1.4K2016: $23.8K2017: $20.6K2023: $2.8K2024: $3.2K$3.2K2012Capital Expenditures (USD)2024Fiscal YearCapital ExpendituresChange YoY2024$3.2K+16.9%2023$2.8K—2017$20.6K-13.3%2016$23.8K+1599.4%2015$1.4K-87.3%2014$11.0K-60.2%2013$27.7K-91.7%2012$334.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share